Business · 31/07/2006Updated: 10/17/2026 · 1 min read
FDA Announces Approval of Guidance for Clinical Trial Data Monitoring Committees
Summary
The Food and Drug Administration (FDA) has received approval from the Office of Management and Budget (OMB) to collect information on the establishment and operation of clinical trial data monitoring committees, as outlined in the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →